XML 37 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Debt (Tables)
9 Months Ended
Sep. 30, 2025
Debt Disclosures  
Schedule of debt

Debt consisted of the following (in thousands):

Balance Outstanding as of

September 30, 2025

September 30,

December 31,

Rate Type

Interest Rate

Maturity Date

2025

2024

(unaudited)

Unsecured Corporate Credit Facilities (1)

Term Loan 1

(2)

Fixed

4.68

%

January 24, 2029

$

185,000

$

175,000

Term Loan 2

(3)

Fixed

5.34

%

January 24, 2030

275,000

175,000

Term Loan 3

(4)

Floating

5.53

%

January 24, 2031

300,000

225,000

Term Loan 4

(5)

N/A

N/A

N/A

100,000

Total unsecured corporate credit facilities

$

760,000

$

675,000

Unsecured Senior Notes

Series A

Fixed

4.69

%

January 10, 2026

$

65,000

$

65,000

Series B

Fixed

4.79

%

January 10, 2028

105,000

105,000

Total unsecured senior notes

$

170,000

$

170,000

Total debt

930,000

845,000

Unamortized deferred financing costs

(12,548)

(3,953)

Debt, net of unamortized deferred financing costs

$

917,452

$

841,047

(1)The variable interest rates on the Company’s unsecured corporate credit facilities are based on a pricing grid depending on the Company’s leverage ratio plus SOFR.
(2)New Term Loan 1 is currently subject to one interest rate swap derivative (see Note 4). New Term Loan 1 has an initial maturity of January 24, 2029 with two twelve-month options to extend at the Company’s election, which would result in an extended maturity of January 24, 2031, upon the payment of applicable fees and the satisfaction of certain customary conditions.
(3)New Term Loan 2 is subject to three interest rate swap derivatives (see Note 4). New Term Loan 2 has an initial maturity of January 24, 2030 with one twelve-month option to extend at the Company’s election, which would result in an extended maturity of January 24, 2031, upon the payment of applicable fees and the satisfaction of certain customary conditions.
(4)New Term Loan 3 is subject to one interest rate swap derivative (see Note 4) covering a partial balance of $25.0 million.
(5)Term Loan 4 was consolidated into the New Term Loans in conjunction with the Company’s Amended Credit Agreement.
Schedule of interest expense

Total interest incurred and expensed on the Company’s debt was as follows (unaudited and in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

    

2025

    

2024

    

2025

    

2024

Interest expense on debt

$

12,927

$

12,395

$

37,209

$

37,012

Noncash interest on derivatives, net

(495)

3,326

668

1,095

Amortization of deferred financing costs

980

741

2,782

2,219

Capitalized interest

(480)

(1,401)

(641)

Total interest expense

$

13,412

$

15,982

$

39,258

$

39,685